Literature DB >> 21255612

Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors.

Stefanie L Bronson1, Rebecca Ahlbrand, Paul S Horn, Joseph R Kern, Neil M Richtand.   

Abstract

Maternal infection during pregnancy elevates risk for schizophrenia and related disorders in offspring. Converging evidence suggests the maternal inflammatory response mediates the interaction between maternal infection, altered brain development, and behavioral outcome. The extent to which individual differences in the maternal response to immune challenge influence the development of these abnormalities is unknown. The present study investigated the impact of individual differences in maternal response to the viral mimic polyinosinic:polycytidylic acid (poly I:C) on offspring behavior. We observed significant variability in body weight alterations of pregnant rats induced by administration of poly I:C on gestational day 14. Furthermore, the presence or absence of maternal weight loss predicted MK-801 and amphetamine stimulated locomotor abnormalities in offspring. MK-801 stimulated locomotion was altered in offspring of all poly I:C treated dams; however, the presence or absence of maternal weight loss resulted in decreased and modestly increased locomotion, respectively. Adult offspring of poly I:C treated dams that lost weight exhibited significantly decreased amphetamine stimulated locomotion, while offspring of poly I:C treated dams without weight loss performed similarly to vehicle controls. Social isolation and increased maternal age predicted weight loss in response to poly I:C but not vehicle injection. In combination, these data identify environmental factors associated with the maternal response to immune challenge and functional outcome of offspring exposed to maternal immune activation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255612      PMCID: PMC3064713          DOI: 10.1016/j.bbr.2010.12.040

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  79 in total

1.  Behavioral characterization of d- and l-amphetamine: neurochemical implications.

Authors:  D S Segal
Journal:  Science       Date:  1975-10-31       Impact factor: 47.728

2.  Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia.

Authors:  Lee Zuckerman; Moshe Rehavi; Rachel Nachman; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

3.  Prenatal immune challenge affects growth, behavior, and brain dopamine in offspring.

Authors:  Jan Bakos; Roman Duncko; Aikaterini Makatsori; Zdeno Pirnik; Alexander Kiss; Daniela Jezova
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

4.  Effect of social isolation on stress-related behavioural and neuroendocrine state in the rat.

Authors:  Isabelle C Weiss; Christopher R Pryce; Ana L Jongen-Rêlo; Nina I Nanz-Bahr; Joram Feldon
Journal:  Behav Brain Res       Date:  2004-07-09       Impact factor: 3.332

5.  Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring.

Authors:  Marie-Eve Fortier; Ridha Joober; Giamal N Luheshi; Patricia Boksa
Journal:  J Psychiatr Res       Date:  2004 May-Jun       Impact factor: 4.791

6.  Effects of ethanol or rimcazole on dizocilpine maleate-induced behaviors in male and female rats.

Authors:  Leslie L Devaud
Journal:  Alcohol       Date:  2003-02       Impact factor: 2.405

7.  Schizophrenic birth seasonality in relation to the incidence of infectious diseases and temperature extremes.

Authors:  C G Watson; T Kucala; C Tilleskjor; L Jacobs
Journal:  Arch Gen Psychiatry       Date:  1984-01

8.  The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism.

Authors:  Marie-Eve Fortier; Stephen Kent; Helen Ashdown; Stephen Poole; Patricia Boksa; Giamal N Luheshi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-06-17       Impact factor: 3.619

9.  Serologic evidence of prenatal influenza in the etiology of schizophrenia.

Authors:  Alan S Brown; Melissa D Begg; Stefan Gravenstein; Catherine A Schaefer; Richard J Wyatt; Michaeline Bresnahan; Vicki P Babulas; Ezra S Susser
Journal:  Arch Gen Psychiatry       Date:  2004-08

10.  Prenatal protein deprivation in rats induces changes in prepulse inhibition and NMDA receptor binding.

Authors:  Abraham A Palmer; David J Printz; Pamela D Butler; Stephanie C Dulawa; Morton P Printz
Journal:  Brain Res       Date:  2004-01-23       Impact factor: 3.252

View more
  19 in total

1.  Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC.

Authors:  Charles V Vorhees; Devon L Graham; Amanda A Braun; Tori L Schaefer; Matthew R Skelton; Neil M Richtand; Michael T Williams
Journal:  Synapse       Date:  2012-05-15       Impact factor: 2.562

2.  Variability in PolyIC induced immune response: Implications for preclinical maternal immune activation models.

Authors:  Milo Careaga; Sandra L Taylor; Carolyn Chang; Alex Chiang; Katherine M Ku; Robert F Berman; Judy A Van de Water; Melissa D Bauman
Journal:  J Neuroimmunol       Date:  2018-06-28       Impact factor: 3.478

3.  Altered serine/threonine kinase activity in schizophrenia.

Authors:  Jennifer L McGuire; John H Hammond; Stefani D Yates; Dongquan Chen; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Brain Res       Date:  2014-04-26       Impact factor: 3.252

4.  Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation.

Authors:  Neil M Richtand; Rebecca Ahlbrand; Paul Horn; Kevin Stanford; Stefanie L Bronson; Robert K McNamara
Journal:  J Psychiatr Res       Date:  2011-03-25       Impact factor: 4.791

5.  Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response.

Authors:  Neil M Richtand; Rebecca Ahlbrand; Paul Horn; Rabindra Tambyraja; Molly Grainger; Stefanie L Bronson; Robert K McNamara
Journal:  Physiol Behav       Date:  2012-02-09

6.  Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy.

Authors:  J G Howland; B N Cazakoff; Y Zhang
Journal:  Neuroscience       Date:  2011-11-11       Impact factor: 3.590

7.  Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat.

Authors:  Neil M Richtand; Rebecca Ahlbrand; Paul S Horn; Brad Chambers; Jon Davis; Stephen Benoit
Journal:  Psychopharmacology (Berl)       Date:  2012-07       Impact factor: 4.530

8.  Prenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine.

Authors:  Charles V Vorhees; Devon L Graham; Amanda A Braun; Tori L Schaefer; Matthew R Skelton; Neil M Richtand; Michael T Williams
Journal:  Neurotoxicol Teratol       Date:  2014-11-08       Impact factor: 3.763

9.  Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: implications for neurodevelopmental psychiatric disorders.

Authors:  Stephanie A Ballendine; Quentin Greba; Wojciech Dawicki; Xiaobei Zhang; John R Gordon; John G Howland
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-12       Impact factor: 5.067

Review 10.  Maternal immune activation: Implications for neuropsychiatric disorders.

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Science       Date:  2016-08-19       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.